| Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ... The lancet oncology 15 (4), 406-414, 2014 | 501 | 2014 |
| Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized … JY Pierga, FC Bidard, C Mathiot, E Brain, S Delaloge, S Giachetti, ... Clinical Cancer Research 14 (21), 7004-7010, 2008 | 355 | 2008 |
| Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays AE Saliba, L Saias, E Psychari, N Minc, D Simon, FC Bidard, C Mathiot, ... Proceedings of the National Academy of Sciences 107 (33), 14524-14529, 2010 | 314 | 2010 |
| High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for … JY Pierga, D Hajage, T Bachelot, S Delaloge, E Brain, M Campone, ... Annals of oncology 23 (3), 618-624, 2011 | 242 | 2011 |
| Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer FC Bidard, C Mathiot, S Delaloge, E Brain, S Giachetti, P De Cremoux, ... Annals of Oncology 21 (4), 729-733, 2009 | 241 | 2009 |
| Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle L De Mattos-Arruda, B Weigelt, J Cortes, HH Won, CKY Ng, P Nuciforo, ... Annals of oncology 25 (9), 1729-1735, 2014 | 226 | 2014 |
| Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials FC Bidard, T Fehm, M Ignatiadis, JB Smerage, C Alix-Panabières, ... Cancer and Metastasis Reviews, 1-10, 2012 | 219 | 2012 |
| Circulating tumor DNA as a non‐invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types R Lebofsky, C Decraene, V Bernard, M Kamal, A Blin, Q Leroy, T Rio Frio, ... Molecular oncology 9 (4), 783-790, 2015 | 186 | 2015 |
| Pooled analysis of the prognostic relevance of circulating tumor cells in primary breast cancer WJ Janni, B Rack, LWMM Terstappen, JY Pierga, FA Taran, T Fehm, ... Clinical cancer research 22 (10), 2583-2593, 2016 | 157 | 2016 |
| Microfluidic: an innovative tool for efficient cell sorting J Autebert, B Coudert, FC Bidard, JY Pierga, S Descroix, L Malaquin, ... Methods 57 (3), 297-307, 2012 | 144 | 2012 |
| Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy FC Bidard, C Mathiot, A Degeorges, MC Etienne-Grimaldi, R Delva, ... Annals of Oncology 21 (9), 1765-1771, 2010 | 139 | 2010 |
| A “class action” against the microenvironment: do cancer cells cooperate in metastasis? FC Bidard, JY Pierga, A Vincent-Salomon, MF Poupon Cancer and Metastasis Reviews 27 (1), 5-10, 2008 | 138 | 2008 |
| Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study JY Pierga, T Petit, T Delozier, JM Ferrero, M Campone, J Gligorov, ... The lancet oncology 13 (4), 375-384, 2012 | 137 | 2012 |
| Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial FC Bidard, F Huguet, C Louvet, L Mineur, O Bouche, B Chibaudel, P Artru, ... Annals of oncology 24 (8), 2057-2061, 2013 | 135 | 2013 |
| Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse FC Bidard, A Vincent-Salomon, S Gomme, C Nos, Y de Rycke, JP Thiery, ... Clinical Cancer Research 14 (11), 3306-3311, 2008 | 133 | 2008 |
| Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells FC Bidard, A Vincent-Salomon, B Sigal-Zafrani, V Dieras, C Mathiot, ... Annals of Oncology 19 (3), 496-500, 2008 | 126 | 2008 |
| Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma FC Bidard, J Madic, P Mariani, S Piperno‐Neumann, A Rampanou, ... International journal of cancer 134 (5), 1207-1213, 2014 | 112 | 2014 |
| Survival of breast cancer patients with meningeal carcinomatosis H Gauthier, MN Guilhaume, FC Bidard, JY Pierga, V Girre, PH Cottu, ... Annals of oncology 21 (11), 2183-2187, 2010 | 112 | 2010 |
| Going with the flow: from circulating tumor cells to DNA FC Bidard, B Weigelt, JS Reis-Filho Science translational medicine 5 (207), 207ps14-207ps14, 2013 | 109 | 2013 |
| Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 ‘triple-negative’breast cancers FC Bidard, R Conforti, T Boulet, S Michiels, S Delaloge, F Andre Annals of oncology 18 (7), 1285-1286, 2007 | 109 | 2007 |
